ALZ-801
ALZ-801 is an orally administered prodrug of tramiprosate, designed with improved pharmacokinetics and tolerability. It functions as a β-amyloid anti-oligomer agent, inhibiting Aβ aggregation, and is applied in Alzheimer's disease research using in vitro and in vivo experimental models.
Product Specifications
CAS Number
1034190-08-3
Product Name Alternative
Valiltramiprosate, β Amyloid, β-amyloid peptide, βAmyloid, β-amyloid, Tramiprosate, disease, BetaAmyloid, Beta Amyloid, b Amyloid, Amyloid-β, bAmyloid, ALZ801, ALZ-801, Alzheimer, ALZ 801, Abeta, Inhibitor, inhibit
Field of Research
Neuroscience
Purity
98.00% (May vary between batches)
Solubility
DMSO:< 1 mg/mL (insoluble) ; H2O:130 mg/mL (545.53 mM)
Smiles
CC (C) [C@H] (N) C (=O) NCCCS (O) (=O) =O
Molecular Formula
C8H18N2O4S
Molecular Weight
238.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1002386-01 100 mg
(1R,7aR) -Hexahydro-1H-pyrrolizin-1-amine compound with (1S,7aR) -hexahydro-1H-pyrrolizin-1-amine (1:1)
Sign In for Pricing
View Details OR1002386-02 250 mg
(1R,7aR) -Hexahydro-1H-pyrrolizin-1-amine compound with (1S,7aR) -hexahydro-1H-pyrrolizin-1-amine (1:1)
Sign In for Pricing
View Details OR1002386-03 1 g
(1R,7aR) -Hexahydro-1H-pyrrolizin-1-amine compound with (1S,7aR) -hexahydro-1H-pyrrolizin-1-amine (1:1)
Sign In for Pricing
View Details 
G8170-53E-FITC 200 µL
GSK3B, NT (Glycogen Synthase Kinase-3 beta, GSK-3 beta) (FITC) discontinued
Sign In for Pricing
View Details